Zeinab Tavakkol Afshari; Hamid Reza Rahimi; Seyed Morteza Ehteshamfar; Rashin Ganjali; Fatemeh Tara; Abbas Shapouri Moghadam
Volume 13, Issue 4 , December 2016, , Pages 309-316
Abstract
Background: Pre-eclampsia is the most common critical condition during pregnancy.
Plasma concentrations of tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta
(IL-1β) increase in pregnant women with pre-eclampsia, compared to normal pregnant
women. Objective: To investigate the polymorphisms ...
Read More
Background: Pre-eclampsia is the most common critical condition during pregnancy.
Plasma concentrations of tumor necrosis factor-alpha (TNF-α) and interleukin-1-beta
(IL-1β) increase in pregnant women with pre-eclampsia, compared to normal pregnant
women. Objective: To investigate the polymorphisms of IL-1β (C+3954T), TNF-α (G-
308A), and (G-238A) in preeclemptic women northeastern Iran. Methods: This study
was conducted on 153 preeclamptic women (case group) and 150 healthy pregnant
women (control group), admitted to Ghaem and Imam Reza hospitals of Mashhad, Iran.
IL-1β (C+3954T), TNF- α (G-238A) and TNF-α (G-308A) gene polymorphisms in the
promoter region were screened by polymerase chain reaction. Data were analyzed,
using SPSS version 16.0. Results: The mean age of the participants in the case and
control groups was 28.2 ± 6.1 and 27.1 ± 6.3 years, respectively (P=0.68). The
frequency of G-308A polymorphism was significantly higher in the case group,
compared to the control group (p<0.001). However, no significant relationship was
found between IL-1β genotype and pre-eclampsia (p=0.39). The frequency of TNF- α
(G-238A) AA genotype was significantly higher in the case group, while GG genotype
was less frequently detected in the case group, compared to the control group (p<0.001
for both genotypes). Moreover, the frequencies of AA genotypes of -238 TNF-α and G-
308A polymorphisms were significantly higher in the case group, compared to the
control group (p<0.001). Conclusion: The significant correlation between inflammation
promoting genotypes of TNF-α and Pre-eclampsia is noteworthy and provides evidence
on the contribution of immune related genes in this disease.
Shahriar Shahriari; Aliasghar Rezaei; Seyed Mohsen Jalazadeh; Khosro Mani; Alireza Zamani
Volume 8, Issue 3 , September 2011, , Pages 176-182
Abstract
Background: Bone resorption is one of the main features of inflammatory periapical lesions and is mainly mediated by interleukin-1 beta (IL-1β), tumor necrosis factoralpha (TNF-α) and prostaglandin-E2 (PGE2). Recent investigations of these lesions revealed that pharmacological modulation may ...
Read More
Background: Bone resorption is one of the main features of inflammatory periapical lesions and is mainly mediated by interleukin-1 beta (IL-1β), tumor necrosis factoralpha (TNF-α) and prostaglandin-E2 (PGE2). Recent investigations of these lesions revealed that pharmacological modulation may be possible. Objective: The aim of this study was to evaluate the effect of Ibuprofen on IL-1β, TNF-α and PGE2 levels in periapical exudates and compare the results with a group of placebo control. Methods: Thirty patients with non vital teeth and radiographic lesions were divided into two groups of case and control according to their entrance to the study. Periapical exudates were taken from root canals using absorbent paper points and followed by 400 mg Ibuprofen and placebo prescribed one tablet every 6 hour for three days and in the fourth day second samples were taken, then final cleaning, shaping and obturation of the canals were completed. IL-1β, TNF-α and PGE2 levels were determined by enzymelinked immunosorbent assays (ELISA). Data were analyzed using paired t-test and student's t-test. Results: The results showed that PGE2 levels were decreased significantly in the case group to 86.92 ± 72.42 Pg/ml following Ibuprofen treatment comparing with the pre-treatment (164.96 ± 12.255 Pg/ml) (p=0.02) and placebo group (154.2 ± 97.13 Pg/ml) (p=0.001). But there were no significant differences in IL-1β and TNF-α level between the two groups and in each group before and after treatment. Conclusion: The data indicate that Ibuprofen, as a non-steroidal anti-inflammatory drug (NSAID), can be used to block PGE2 release, enhance healing of inflammatory periapical lesions and possibly to inhibit bone resorption.
